Scholarly Index
Robert Schmouder
Novartis (United States); 6,717 total citations; 109 total publications; best world rank #338
Novartis (United States)
6,717Total citations
109Total publications
35H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Sphingolipid Metabolism and Signaling | Lifetime | 338 | US 140 | 94.91 |
| Complement system in diseases | 2021-2025 | 464 | US 115 | 80.32 |
| Pharmaceutical studies and practices | 2021-2025 | 873 | US 267 | 74.94 |